iBio
IBIO
17 hedge funds and large institutions have $2.38M invested in iBio in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
6% more funds holding
Funds holding: 16 → 17 (+1)
0% less ownership
Funds ownership: 0% → 0% (-0%)
29% less capital invested
Capital invested by funds: $3.37M → $2.38M (-$987K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.65K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$4.65K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.33K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$2.33K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JFA
JNBA Financial Advisors
Bloomington,
Minnesota
|
-$84K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$6K |
| 3 |
Bank of New York Mellon
New York
|
-$2.33K |
IBIO Hedge Fund Activity: Q4 2016 in Review
17 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q4 2016, worth a combined $2.38M — down 29% from $3.37M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new IBIO positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Royal Bank of Canada, opening a new position worth an estimated $4.65K. The largest seller was JNBA Financial Advisors, exiting entirely with an estimated $84K sold.
- 17 institutional investors held iBio (IBIO) as of Q4 2016, up from 16 in Q3 2016.
- Funds reported $2.38M of iBio stock for Q4 2016, down 29% quarter-over-quarter.
- 3 funds opened new iBio positions in Q4 2016 and 2 closed out, a net change of +1 holder.
- The largest iBio buyer in Q4 2016 was Royal Bank of Canada, an estimated $4.65K added.
- The largest iBio seller in Q4 2016 was JNBA Financial Advisors, an estimated $84K sold.
Based on aggregated 13F filings for Q4 2016.